The UCOM, PCDHGB7, efficiently distinguishes high-grade squamous intraepithelial lesions (HSILs) and cervical cancer from normal samples and low-grade squamous intraepithelial lesions (LSILs), while most other biomarkers can only differentiate cervical cancer from normal samples30. This evidence concerns the gene PCDHGB7 and cervical cancer.